Literature DB >> 22128130

Multidetector CT features of pulmonary focal ground-glass opacity: differences between benign and malignant.

L Fan1, S-Y Liu, Q-C Li, H Yu, X-S Xiao.   

Abstract

OBJECTIVE: To evaluate different features between benign and malignant pulmonary focal ground-glass opacity (fGGO) on multidetector CT (MDCT).
METHODS: 82 pathologically or clinically confirmed fGGOs were retrospectively analysed with regard to demographic data, lesion size and location, attenuation value and MDCT features including shape, margin, interface, internal characteristics and adjacent structure. Differences between benign and malignant fGGOs were analysed using a χ(2) test, Fisher's exact test or Mann-Whitney U-test. Morphological characteristics were analysed by binary logistic regression analysis to estimate the likelihood of malignancy.
RESULTS: There were 21 benign and 61 malignant lesions. No statistical differences were found between benign and malignant fGGOs in terms of demographic data, size, location and attenuation value. The frequency of lobulation (p=0.000), spiculation (p=0.008), spine-like process (p=0.004), well-defined but coarse interface (p=0.000), bronchus cut-off (p=0.003), other air-containing space (p=0.000), pleural indentation (p=0.000) and vascular convergence (p=0.006) was significantly higher in malignant fGGOs than that in benign fGGOs. Binary logistic regression analysis showed that lobulation, interface and pleural indentation were important indicators for malignant diagnosis of fGGO, with the corresponding odds ratios of 8.122, 3.139 and 9.076, respectively. In addition, a well-defined but coarse interface was the most important indicator of malignancy among all interface types. With all three important indicators considered, the diagnostic sensitivity, specificity and accuracy were 93.4%, 66.7% and 86.6%, respectively.
CONCLUSION: An fGGO with lobulation, a well-defined but coarse interface and pleural indentation gives a greater than average likelihood of being malignant.

Entities:  

Mesh:

Year:  2011        PMID: 22128130      PMCID: PMC3474071          DOI: 10.1259/bjr/33150223

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  26 in total

1.  Evolution of peripheral lung adenocarcinomas: CT findings correlated with histology and tumor doubling time.

Authors:  T Aoki; H Nakata; H Watanabe; K Nakamura; T Kasai; H Hashimoto; K Yasumoto; M Kido
Journal:  AJR Am J Roentgenol       Date:  2000-03       Impact factor: 3.959

2.  Value of multiplanar reconstruction in MSCT in demonstrating the relationship between solitary pulmonary nodule and bronchus.

Authors:  Yun Cui; Da-Qing Ma; Wei-Hua Liu
Journal:  Clin Imaging       Date:  2009 Jan-Feb       Impact factor: 1.605

Review 3.  Nodular ground-glass opacity at thin-section CT: histologic correlation and evaluation of change at follow-up.

Authors:  Chang Min Park; Jin Mo Goo; Hyun Ju Lee; Chang Hyun Lee; Eun Ju Chun; Jung-Gi Im
Journal:  Radiographics       Date:  2007 Mar-Apr       Impact factor: 5.333

4.  Focal ground-glass opacity detected by low-dose helical CT.

Authors:  Masao Nakata; Hideyuki Saeki; Ichiro Takata; Yoshihiko Segawa; Hiroshi Mogami; Koichi Mandai; Kenji Eguchi
Journal:  Chest       Date:  2002-05       Impact factor: 9.410

5.  CT screening for lung cancer: frequency and significance of part-solid and nonsolid nodules.

Authors:  Claudia I Henschke; David F Yankelevitz; Rosna Mirtcheva; Georgeann McGuinness; Dorothy McCauley; Olli S Miettinen
Journal:  AJR Am J Roentgenol       Date:  2002-05       Impact factor: 3.959

6.  Clinical, pathological and thin-section CT features of persistent multiple ground-glass opacity nodules: comparison with solitary ground-glass opacity nodule.

Authors:  Tae Jung Kim; Jin Mo Goo; Kyung Won Lee; Chang Min Park; Hyun Ju Lee
Journal:  Lung Cancer       Date:  2008-09-16       Impact factor: 5.705

7.  Persistent pulmonary nodular ground-glass opacity at thin-section CT: histopathologic comparisons.

Authors:  Ha Young Kim; Young Mog Shim; Kyung Soo Lee; Joungho Han; Chin A Yi; Yoon Kyung Kim
Journal:  Radiology       Date:  2007-10       Impact factor: 11.105

8.  Empirical description of bronchial and nonbronchial arteries with MDCT.

Authors:  Hong Yu; Shi-Yuan Liu; Hui-Min Li; Xiang-Sheng Xiao; Wei-Hua Dong
Journal:  Eur J Radiol       Date:  2009-05-22       Impact factor: 3.528

9.  Focal organizing pneumonia: CT and pathologic findings.

Authors:  P S Yang; K S Lee; J Han; E A Kim; T S Kim; I W Choo
Journal:  J Korean Med Sci       Date:  2001-10       Impact factor: 2.153

10.  Nodular ground-glass opacities on thin-section CT: size change during follow-up and pathological results.

Authors:  Hyun Ju Lee; Jin Mo Goo; Chang Hyun Lee; Chul-Gyu Yoo; Young Tae Kim; Jung-Gi Im
Journal:  Korean J Radiol       Date:  2007 Jan-Feb       Impact factor: 3.500

View more
  34 in total

1.  Diagnostic value of computed tomography scanning in differentiating malignant from benign solitary pulmonary nodules: a meta-analysis.

Authors:  Chuan-Yu Zhang; Hua-Long Yu; Xia Li; Yong-Ye Sun
Journal:  Tumour Biol       Date:  2014-05-26

2.  CT diagnosis of pleural and stromal invasion in malignant subpleural pure ground-glass nodules: an exploratory study.

Authors:  Qing Zhao; Jian-Wei Wang; Lin Yang; Li-Yan Xue; Wen-Wen Lu
Journal:  Eur Radiol       Date:  2018-06-25       Impact factor: 5.315

3.  Surgery for undiagnosed ground glass pulmonary nodules: decision making using serial computed tomography.

Authors:  Kazuhiro Ueda; Masataro Hayashi; Nobuyuki Tanaka; Yoshinobu Hoshii; Toshiki Tanaka; Kimikazu Hamano
Journal:  World J Surg       Date:  2015-06       Impact factor: 3.352

4.  Radiological Image Traits Predictive of Cancer Status in Pulmonary Nodules.

Authors:  Ying Liu; Yoganand Balagurunathan; Thomas Atwater; Sanja Antic; Qian Li; Ronald C Walker; Gary T Smith; Pierre P Massion; Matthew B Schabath; Robert J Gillies
Journal:  Clin Cancer Res       Date:  2016-09-23       Impact factor: 12.531

5.  Radiomics signature: a biomarker for the preoperative discrimination of lung invasive adenocarcinoma manifesting as a ground-glass nodule.

Authors:  Li Fan; MengJie Fang; ZhaoBin Li; WenTing Tu; ShengPing Wang; WuFei Chen; Jie Tian; Di Dong; ShiYuan Liu
Journal:  Eur Radiol       Date:  2018-07-02       Impact factor: 5.315

6.  Comparing the diagnostic value of 18F-FDG-PET/CT versus CT for differentiating benign and malignant solitary pulmonary nodules: a meta-analysis.

Authors:  Yuzhu Jia; Wanfeng Gong; Zhiping Zhang; Gaofeng Tu; Jiapeng Li; Fanfan Xiong; Hongtao Hou; Yunyi Zhang; Meiqian Wu; Liping Zhang
Journal:  J Thorac Dis       Date:  2019-05       Impact factor: 2.895

7.  Radiomic features from computed tomography to differentiate invasive pulmonary adenocarcinomas from non-invasive pulmonary adenocarcinomas appearing as part-solid ground-glass nodules.

Authors:  Ting Luo; Ke Xu; Zheng Zhang; Lina Zhang; Shandong Wu
Journal:  Chin J Cancer Res       Date:  2019-04       Impact factor: 5.087

8.  Dependence of radiomic features on pixel size affects the diagnostic performance of radiomic signature for the invasiveness of pulmonary ground-glass nodule.

Authors:  Guangyu Tao; Lekang Yin; Dejun Shi; Jianding Ye; Zhenghai Lu; Zhen Zhou; Yizhou Yu; Xiaodan Ye; Hong Yu
Journal:  Br J Radiol       Date:  2020-12-22       Impact factor: 3.039

9.  Qualitative and quantitative imaging features of pulmonary subsolid nodules: differentiating invasive adenocarcinoma from minimally invasive adenocarcinoma and preinvasive lesions.

Authors:  Linlin Qi; Wenwen Lu; Lin Yang; Wei Tang; Shijun Zhao; Yao Huang; Ning Wu; Jianwei Wang
Journal:  J Thorac Dis       Date:  2019-11       Impact factor: 2.895

10.  High-resolution computed tomography features and CT-guided microcoil localization of subcentimeter pulmonary ground-glass opacities: radiological processing prior to video-assisted thoracoscopic surgery.

Authors:  Zi-Xuan Wang; Lin Li; Zhe Zhang; Guo-Hua Wang; De-Mao Kong; Xu-Dong Wang; Fa Wang
Journal:  J Thorac Dis       Date:  2018-05       Impact factor: 2.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.